Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Icotrokinra in Moderate to Severe Ulcerative Colitis (Adults and Adolescents)
CTR20254443Phase 3Active
- Sponsor
- Janssen Pharmaceutical
- Start
- Dec 2025
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 3 trial of icotrokinra in autoimmune colitis, sponsored by Janssen Pharmaceutical. Started Dec 2025; status: active.
02
Drugs
icotrokinra
03
Conditions
autoimmune colitis
Beyond the preview
Go deeper on CTR20254443.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20254443.